X4 Pharmaceuticals, Inc. (XFOR) has a MoatMap StockRank of 39/100 based on Quality (29/100), Value (40/100), and Momentum (59/100) factor scores. The current signal is HOLD. X4 Pharmaceuticals, Inc. (US, Healthcare) is a small-cap biotech, making it a speculative investment dependent on specific drug development, not macro themes. This does not align with the fund's macro thematic investment approach or criteria for quality compounders.